Use of the Sustained Pain-Free Plus No Adverse Events Endpoint in Clinical Trials of Triptans in Acute Migraine

ISSN： 1172-7047

Source： CNS Drugs, Vol.21, Iss.1, 2007-01, pp. : 73-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Use of Triptans in the Management of Menstrual Migraine

By Mannix Lisa K.

CNS Drugs, Vol. 19, Iss. 11, 2005-01 ,pp. : 951-972

Adis International

Access to resources Recommend Favorite

Clinical and Economic Comparison of Frovatriptan Versus other Oral Triptans in the Treatment of Acute Migraine in the Real-World Setting

By Guidotti Mario

Clinical Drug Investigation, Vol. 29, Iss. 11, 2009-11 ,pp. : 693-702

Adis International

Access to resources Recommend Favorite

Statistical Methods to Analyze Adverse Events Data of Randomized Clinical Trials

By Siddiqui Ohidul

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 5, 2009-09 ,pp. : 889-899

Taylor & Francis Ltd

Access to resources Recommend Favorite

Short-Term Acetylsalicylic Acid (Aspirin) Use for Pain, Fever, or Colds - Gastrointestinal Adverse Effects: A Meta-Analysis of Randomized Clinical Trials

By Lanas Angel

Drugs in R&D, Vol. 11, Iss. 3, 2011-09 ,pp. : 277-288

Adis International

Access to resources Recommend Favorite

Migraine pharmacotherapy with oral triptans: a rational approach to clinical management

By Millson D.S. Tepper S.J. Rapoport A.M.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 391-404

Informa Healthcare

Access to resources Recommend Favorite